SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about company updates

25 Feb 2017 Evaluate

Sun Pharma Advanced Research Company has informed that the Company is in receipt of a Demand Notice under section 156 of the Income Tax, 1961 demanding the payment by the Company of a sum of Rs 32.87 crores for the Assessment year 2013-14. The Company is contesting the demand and would file an appropriate appeal against this order under the applicable provisions of the Income Tax Act, 1961 within the stipulated period.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

144.55 -3.35 (-2.27%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.55
Indegene 482.65
CMS Info Systems 317.60
JITF Infralogistics 331.25
Sagility 42.17
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×